<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04720053</url>
  </required_header>
  <id_info>
    <org_study_id>20-003020</org_study_id>
    <nct_id>NCT04720053</nct_id>
  </id_info>
  <brief_title>Evaluating Mindfulness-Based Interventions With New Fibromyalgia Patients</brief_title>
  <official_title>A Feasibility Study Evaluating Mindfulness-Based Intervention Assessing- A Wearable Wellness Brain Sensing Device (Muse-S) in Newly Diagnosed Fibromyalgia Patients.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to study the feasibility of a wearable brain sensing wellness&#xD;
      device to provide mindfulness training to fibromyalgia patients who have failed medical&#xD;
      therapy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      All study participants will receive a wearable brain sensing wellness device, and&#xD;
      demonstration of the mindfulness sessions. Participants will be asked to complete study&#xD;
      surveys/questionnaires. During the first part of study, participants will be asked to&#xD;
      complete the intervention. After completion of the intervention they will enter a follow-Up&#xD;
      Phase, where they will be contacted and asked to complete surveys and gauge satisfaction with&#xD;
      the study.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2021</start_date>
  <completion_date type="Anticipated">November 2022</completion_date>
  <primary_completion_date type="Anticipated">November 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in wide pain index (WPI)</measure>
    <time_frame>Baseline, end of treatment day 90, and at the end of study day 180</time_frame>
    <description>Wide pain index (WPI) defined as a 4-quadrant plus axial pain, measuring widespread pain in 19 specific places on both sides of the body, above and below the waist</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in symptom severity score</measure>
    <time_frame>Baseline, end of treatment day 90, and at the end of study day 180</time_frame>
    <description>Measured on a 0-10 pain assessment scale. Participants rate their pain on a scale of 0 to 10. Zero means &quot;no pain,&quot; and 10 means &quot;the worst possible pain&quot;.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Fibromyalgia</condition>
  <arm_group>
    <arm_group_label>Wearable brain sensing wellness device headband system</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subject diagnosed with fibromyalgia at Mayo Clinic GIM Fibromyalgia Clinic will receive a wearable brain sensing wellness device headband system, and will be given a demonstration of the mindfulness sessions, with detailed instructions on how to begin each session.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Wearable brain sensing wellness device headband system</intervention_name>
    <description>Brain sensing headband that measures brain activity by detecting electrical impulses created by the brain.</description>
    <arm_group_label>Wearable brain sensing wellness device headband system</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  18 years of age or older at time of consent.&#xD;
&#xD;
          -  Diagnosed with Fibromyalgia.&#xD;
&#xD;
          -  Not pregnant by subject self-report at time of consent.&#xD;
&#xD;
          -  Have the ability to provide informed consent.&#xD;
&#xD;
          -  Have the ability to complete all aspects of this trial.&#xD;
&#xD;
          -  Have access to a iPhone, iPad, Android device.&#xD;
&#xD;
          -  Has no contraindicating comorbid health condition as determined by the clinical&#xD;
             investigators.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Used or been enrolled in any treatments for fibromyalgia, or pain within the past 30&#xD;
             days.&#xD;
&#xD;
          -  Used an investigational drug within the past 30 days.&#xD;
&#xD;
          -  Currently (within the past 3 weeks) been practicing mindfulness training on a&#xD;
             weekly/regular basis.&#xD;
&#xD;
          -  Currently (within the past 3 weeks) been undergoing an additional program (e.g. CAM)&#xD;
             to improve quality of life.&#xD;
&#xD;
          -  Currently (within 3 weeks) been enrolled in another clinical or research program (e.g.&#xD;
             CAM) which intervenes on the patients' QOL, or stress.&#xD;
&#xD;
          -  An unstable medical or mental health condition as determined by the physician&#xD;
             investigator.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sanjeev Nanda, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jennifer Soderlind</last_name>
    <phone>(507) 284-4799</phone>
    <email>GIMRESEARCHSTUDIES@Mayo.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Shawn Fokken</last_name>
    <phone>(507) 293-2740</phone>
    <email>GIMRESEARCHSTUDIES@Mayo.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mayo Clinic in Rochester</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jennifer Soderlind</last_name>
      <email>soderlind.jennifer@mayo.edu</email>
    </contact>
    <contact_backup>
      <last_name>Jennifer Hanson</last_name>
      <email>hanson.jennifer6@mayo.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Sanjeev Nanda</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>January 19, 2021</study_first_submitted>
  <study_first_submitted_qc>January 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 22, 2021</study_first_posted>
  <last_update_submitted>November 2, 2021</last_update_submitted>
  <last_update_submitted_qc>November 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Sanjeev Nanda</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fibromyalgia</mesh_term>
    <mesh_term>Myofascial Pain Syndromes</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

